Currently, there are 328.44M common shares owned by the public and among those 321.31M shares have been available to trade.
The company’s stock has a 5-day price change of 2.45% and -0.61% over the past three months. BILI shares are trading 20.05% year to date (YTD), with the 12-month market performance down to -3.44% lower. It has a 12-month low price of $8.80 and touched a high of $18.19 over the same period. BILI has an average intraday trading volume of 5.99 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.86%, -4.03%, and 13.40% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Bilibili Inc ADR (NASDAQ: BILI) shares accounts for 22.77% of the company’s 328.44M shares outstanding.
It has a market capitalization of $4.69B and a beta (3y monthly) value of 0.82. The earnings-per-share (ttm) stands at -$1.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.21% over the week and 5.12% over the month.
Earnings per share for the fiscal year are expected to increase by 93.47%, and 757.82% over the next financial year.
Looking at the support for the BILI, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on August 23, 2024, with the firm’s price target at $14-$19. Nomura coverage for the Bilibili Inc ADR (BILI) stock in a research note released on August 22, 2024 offered a Buy rating with a price target of $18. Daiwa Securities was of a view on August 22, 2024 that the stock is Outperform, while JP Morgan gave the stock Overweight rating on June 20, 2024, issuing a price target of $21. UBS on their part issued Buy rating on May 31, 2024.
